Durham.

PositionTriangle

DURHAM -- BioMarck, a drug developer that sprang from research at N.C. State University, raised $6.3 million from investors to finish a clinical trial of a treatment for chronic obstructive pulmonary disease. It plans to partner with a large...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT